Observational studyEuropean thyroid journal2025
Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study).
Giulia Puliani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.